Raymond James & Associates’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$493K Sell
52,456
-7,463
-12% -$70.1K ﹤0.01% 3106
2024
Q2
$481K Sell
59,919
-7,371
-11% -$59.1K ﹤0.01% 3079
2024
Q1
$997K Buy
67,290
+50,380
+298% +$747K ﹤0.01% 2581
2023
Q4
$137K Buy
16,910
+3,868
+30% +$31.4K ﹤0.01% 3566
2023
Q3
$59.3K Buy
13,042
+125
+1% +$569 ﹤0.01% 3631
2023
Q2
$90.9K Buy
12,917
+2,700
+26% +$19K ﹤0.01% 3600
2023
Q1
$62.4K Buy
+10,217
New +$62.4K ﹤0.01% 3666
2022
Q4
Sell
-19,863
Closed -$190K 3838
2022
Q3
$190K Buy
19,863
+50
+0.3% +$478 ﹤0.01% 3440
2022
Q2
$219K Buy
19,813
+4,427
+29% +$48.9K ﹤0.01% 3423
2022
Q1
$256K Buy
15,386
+5,350
+53% +$89K ﹤0.01% 3489
2021
Q4
$192K Buy
10,036
+1,797
+22% +$34.4K ﹤0.01% 3682
2021
Q3
$203K Sell
8,239
-8,726
-51% -$215K ﹤0.01% 3632
2021
Q2
$441K Sell
16,965
-2,480
-13% -$64.5K ﹤0.01% 3166
2021
Q1
$616K Sell
19,445
-1,853
-9% -$58.7K ﹤0.01% 2856
2020
Q4
$988K Sell
21,298
-26,151
-55% -$1.21M ﹤0.01% 2349
2020
Q3
$1.56M Buy
47,449
+6,521
+16% +$215K ﹤0.01% 1910
2020
Q2
$1.12M Buy
40,928
+50
+0.1% +$1.37K ﹤0.01% 2077
2020
Q1
$1.22M Buy
40,878
+27,354
+202% +$819K ﹤0.01% 1851
2019
Q4
$374K Sell
13,524
-988
-7% -$27.3K ﹤0.01% 2929
2019
Q3
$264K Sell
14,512
-4,281
-23% -$77.9K ﹤0.01% 3066
2019
Q2
$461K Buy
+18,793
New +$461K ﹤0.01% 2728
2018
Q3
Sell
-52,856
Closed -$677K 3530
2018
Q2
$677K Buy
52,856
+883
+2% +$11.3K ﹤0.01% 2477
2018
Q1
$878K Buy
+51,973
New +$878K ﹤0.01% 2224
2016
Q2
Sell
-13,700
Closed -$70K 2936
2016
Q1
$70K Buy
+13,700
New +$70K ﹤0.01% 2732